May 25, 2017 / 1:20 PM / 3 months ago

BRIEF-Hovione announces start of Phase 1 clinical trial of HY02

May 25 (Reuters) - Hovione

* Hovione announces start of Phase 1 clinical trial of HY02, a proprietary minocycline sterile ointment to treat a subset of anterior ocular inflammation Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below